Standardized monitoring of cytomegalovirus-specific immunity can improve risk stratification of recurrent cytomegalovirus reactivation after hematopoietic stem cell transplantation.
- DOI
- 10.3324/haematol.2019.229252
- Published
- 2021 Feb 1
- Container
- Haematologica
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3324/haematol.2019.229252,
title = {Standardized monitoring of cytomegalovirus-specific immunity can improve risk stratification of recurrent cytomegalovirus reactivation after hematopoietic stem cell transplantation.},
author = {Wagner-Drouet E and Teschner D and Wolschke C and Janson D and Schäfer-Eckart K and Gärtner J and Mielke S and Schreder M and Kobbe G and Kondakci M and Hilgendorf I and von Lilienfeld-Toal M and Klein S and Heidenreich D and Kreil S and Verbeek M and Grass S and Ditschkowski M and Gromke T and Koch M and Lindemann M and Hünig T and Schmidt T and Rascle A and Guldan H and Barabas S and Deml L and Wagner R and Wolff D},
year = {2021},
journal = {Haematologica},
doi = {10.3324/haematol.2019.229252},
url = {https://doi.org/10.3324/haematol.2019.229252}
}RIS
TY - JOUR TI - Standardized monitoring of cytomegalovirus-specific immunity can improve risk stratification of recurrent cytomegalovirus reactivation after hematopoietic stem cell transplantation. AU - Wagner-Drouet E AU - Teschner D AU - Wolschke C AU - Janson D AU - Schäfer-Eckart K AU - Gärtner J AU - Mielke S AU - Schreder M AU - Kobbe G AU - Kondakci M AU - Hilgendorf I AU - von Lilienfeld-Toal M AU - Klein S AU - Heidenreich D AU - Kreil S AU - Verbeek M AU - Grass S AU - Ditschkowski M AU - Gromke T AU - Koch M AU - Lindemann M AU - Hünig T AU - Schmidt T AU - Rascle A AU - Guldan H AU - Barabas S AU - Deml L AU - Wagner R AU - Wolff D PY - 2021 JO - Haematologica DO - 10.3324/haematol.2019.229252 UR - https://doi.org/10.3324/haematol.2019.229252 ER -
APA
E, W., D, T., C, W., D, J., K, S., J, G., S, M., M, S., G, K., M, K., I, H., M, V. L., S, K., D, H., S, K., M, V., S, G., M, D., T, G., M, K., M, L., T, H., T, S., A, R., H, G., S, B., L, D., R, W., & D, W. (2021). Standardized monitoring of cytomegalovirus-specific immunity can improve risk stratification of recurrent cytomegalovirus reactivation after hematopoietic stem cell transplantation.. Haematologica. https://doi.org/10.3324/haematol.2019.229252
Source records
- pubmed · retrieved 2026-09-26T20:50:51.713Z